Synopsis
Keywords: Functional Connectivity, fMRI (resting state), Bright light therapy, amygdala, subthreshold depression, serotoninergic system
Motivation: The presence of subthreshold depression significantly increases the likelihood of developing major depressive disorder and is linked to a higher burden of illness and suicide risk.
Goal(s): The objective of this clinical trial was to evaluate the relationship between BLT and the functional connectivity (FC) alterations of the amygdala, as well as the serotoninergic distribution in subthreshold depression.
Approach: Subthreshold depression subjects were randomly divided into two groups: the BLT group and the placebo group.
Results: BLT group showed increased sFC of right basolateral amygdala (BLA)/superficial amygdala (SFA)-right middle temporal gyrus and dFC of right centralmedial amygdala and right inferior orbital frontal gyrus.
Impact: These findings indicated that BLT could relieve depressive symptoms and
alter FC of the amygdala in subthreshold depression (StD). Combining baseline sFC and
dFC of the amygdala may have the potential to assess the effectiveness of BLT
in treating StD.
Abstract
Background: The presence of subthreshold
depression significantly increases the likelihood of developing major
depressive disorder and is linked to a higher burden of illness and suicide
risk. Although the neural mechanism of bright light therapy (BLT) remains
unclear, it is considered as an effective intervention for subthreshold
depression. The amygdala has been shown to play a critical role in depression.
And light has been associated with the serotoninergic system. The objective of
this clinical trial was to evaluate the relationship between BLT and the functional
connectivity (FC) alterations of the amygdala, as well as the serotoninergic
distribution in subthreshold depression.
Methods: Subthreshold
depression subjects were randomly divided into two groups: the BLT group (N = 47) and the placebo
group (N = 42). The Hamilton Depression Rating Scale (HDRS) was the main
measure of outcome, while the Centre for Epidemiologic Studies Depression Scale
(CESD) and Beck Depression Inventory (BDI) served as secondary measures, which
were evaluated before and after 8 weeks. The participants also underwent
resting-state functional magnetic resonance imaging before and after 8 weeks. Seed-based
whole-brain static FC (sFC) and dynamic FC (dFC) analyses of the bilateral
amygdala and their subfields were conducted. Besides, a multivariate regression
model was utilized to predict HDRS, CESD and BDI scores alterations after BLT. In addition, the JuSpace toolbox was employed to compute
the correlations between sFC/dFC of the amygdala subfields and the serotoninergic
system activity both in the BLT and the placebo group.
Results: BLT group showed decreased CESD score and HDRS score from pre-treatment
to post-treatment compared to the placebo group. Also, compared to baseline,
BLT group showed increased sFC of right basolateral amygdala (BLA)/superficial
amygdala (SFA)-right middle temporal gyrus (MTG) and dFC of right centralmedial
amygdala (CMA) and right inferior orbital frontal gyrus, and decreased sFC of
right amygdalostriatal transition (AStr)/CMA- left thalamus and dFC of right
SFA- right medial prefrontal cortex after intervention. Changes in sFC of the right BLA-right MTG showed
positive correlation with changes in BDI score before and after
BLT. Moreover, combining the baseline sFC and dFC of the amygdala could predict
HDRS, CESD and BDI changes after BLT intervention. Additionally, compared to baseline, sFC of the right BLA alterations
after BLT were significantly associated with spatial distribution of 5HT1a and
5-HT2a receptors, while dFC of the right CMA alterations after BLT were
significantly associated with spatial distribution of 5HT1a receptor.
Conclusions: These findings
indicated that BLT could relieve depressive symptoms and alter FC of the
amygdala in subthreshold depression. Combining baseline sFC and dFC of the
amygdala may have the potential to assess the effectiveness of BLT in treating
subthreshold depression. Moreover, FC changes of the amygdala with the serotoninergic
system after BLT may underline the antidepressant mechanisms of BLT.Acknowledgements
The study was supported by grants from
the National Natural Science Foundation of China (81671670, 81971597, and 82172530); National Key Research
and Development Project (2020YFC2005700); Key-Area Research and Development
Program of Guangdong Province (2020B1111100001). The funding organizations play
no further role in study design, data collection, analysis and interpretation
and paper writing.References
Allen, E. A., Damaraju, E., Plis, S. M., Erhardt, E. B., Eichele,
T., & Calhoun, V. D. (2014). Tracking whole-brain connectivity dynamics in
the resting state. Cereb Cortex, 24,
663-676.
Amunts, K., Kedo, O., Kindler, M., Pieperhoff, P., Mohlberg, H.,
Shah, N. J., . . . Zilles, K. (2005). Cytoarchitectonic mapping of the human
amygdala, hippocampal region and entorhinal cortex: intersubject variability
and probability maps. Anat Embryol (Berl),
210, 343-352.
Baumeister, H. (2012). Inappropriate prescriptions of antidepressant
drugs in patients with subthreshold to mild depression: time for the evidence
to become practice. J Affect Disord, 139,
240-243.
Buntrock, C., Ebert, D. D., Lehr, D., Smit, F., Riper, H., Berking,
M., & Cuijpers, P. (2016). Effect of a Web-Based Guided Self-help
Intervention for Prevention of Major Depression in Adults With Subthreshold
Depression: A Randomized Clinical Trial. Jama, 315, 1854-1863.
Bzdok, D., Laird, A. R., Zilles, K., Fox, P. T., & Eickhoff, S.
B. (2013). An investigation of the structural, connectional, and functional
subspecialization in the human amygdala. Hum Brain Mapp, 34, 3247-3266.
Calhoun, V. D., Miller, R., Pearlson, G., & Adali, T. (2014).
The chronnectome: time-varying connectivity networks as the next frontier in
fMRI data discovery. Neuron, 84,
262-274.
Chen, G., Chen, P., Gong, J., Jia, Y., Zhong, S., Chen, F., . . .
Wang, Y. (2022). Shared and specific patterns of dynamic functional
connectivity variability of striato-cortical circuitry in unmedicated bipolar
and major depressive disorders. Psychol Med,
52, 747-756.
Chen, P., Chen, G., Zhong, S., Chen, F., Ye, T., Gong, J., . . .
Wang, Y. (2022). Thyroid hormones disturbances, cognitive deficits and abnormal
dynamic functional connectivity variability of the amygdala in unmedicated
bipolar disorder. J Psychiatr Res, 150,
282-291.
Cuijpers, P., Pineda, B. S., Ng, M. Y., Weisz, J. R., Muñoz, R. F.,
Gentili, C., . . . Karyotaki, E. (2021). A Meta-analytic Review: Psychological
Treatment of Subthreshold Depression in Children and Adolescents. J Am Acad
Child Adolesc Psychiatry, 60,
1072-1084.
Cuijpers, P., & Smit, F. (2004). Subthreshold depression as a
risk indicator for major depressive disorder: a systematic review of
prospective studies. Acta Psychiatr Scand,
109, 325-331.
Cuijpers, P., Smit, F., Oostenbrink, J., de Graaf, R., Ten Have, M.,
& Beekman, A. (2007). Economic costs of minor depression: a
population-based study. Acta Psychiatr Scand, 115, 229-236.
Cuijpers, P., Vogelzangs, N., Twisk, J., Kleiboer, A., Li, J., &
Penninx, B. W. (2013). Differential mortality rates in major and subthreshold
depression: meta-analysis of studies that measured both. Br J Psychiatry, 202, 22-27.
Davey, C. G., & McGorry, P. D. (2019). Early intervention for
depression in young people: a blind spot in mental health care. Lancet
Psychiatry, 6, 267-272.
Demyttenaere, K., & De Fruyt, J. (2003). Getting what you ask
for: on the selectivity of depression rating scales. Psychother Psychosom, 72, 61-70.
Drevets, W. C. (2003). Neuroimaging abnormalities in the amygdala in
mood disorders. Ann N Y Acad Sci, 985,
420-444.
Dukart, J., Holiga, S., Rullmann, M., Lanzenberger, R., Hawkins, P.
C. T., Mehta, M. A., . . . Eickhoff, S. B. (2021). JuSpace: A tool for spatial
correlation analyses of magnetic resonance imaging data with nuclear imaging
derived neurotransmitter maps. Hum Brain Mapp, 42, 555-566.